Physical Medicine & Rehabilitation · Bristol, CT
NPI
1346416153
Since 2008
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
842 Clark Ave
Bristol, CT, 06010
Phone (860) 582-9355
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
7,496 services
Medicare patients, 2024
97
Average age 69
Drug cost, 2024
$390K
1,148 prescriptions
Company payments, 2025
$182
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Watson was code 95886 (electrical nerve conductivity), 54 times for 38 patients. In total Mark D Watson billed 7,496 services in 34 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 54 | 38 | $86.26 | $4,658 |
| 99213 Office E&M - Established | Office | 54 | 30 | $63.40 | $3,424 |
| 99214 Office E&M - Established | Office | 28 | 14 | $81.89 | $2,293 |
| 20553 Musculoskeletal | Office | 24 | 11 | $41.44 | $995 |
| 95910 Electrical Nerve Conductivity | Office | 22 | 22 | $141.83 | $3,120 |
By year: 2022 $73K for 8,289 services; 2023 $73K for 8,469 services; 2024 $59K for 7,496 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Watson prescribed most often to Medicare patients was Baclofen, with 89 prescriptions and refills. In total Mark D Watson wrote 1,148 Medicare prescriptions that cost $390K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 89 | 107 | 14 | $1,737 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 71 | 71 | Under 11 | $1,536 |
| Gabapentin Generic | 69 | 81 | 12 | $909 |
| Ubrelvy Ubrogepant | 62 | 62 | 12 | $90K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 53 | 53 | Under 11 | $644 |
| Pregabalin Generic | 49 | 61 | Under 11 | $659 |
| Tramadol Hcl Generic | 43 | 43 | Under 11 | $201 |
| Tramadol Hcl Er Tramadol Hcl | 39 | 39 | Under 11 | $3,139 |
| Meloxicam Generic | 38 | 56 | Under 11 | $101 |
| Oxycodone Hcl Generic | 35 | 37 | Under 11 | $508 |
| Qulipta Atogepant | 33 | 39 | Under 11 | $44K |
| Oxycontin Oxycodone Hcl | 32 | 36 | Under 11 | $23K |
| Cyclobenzaprine Hcl Generic | 32 | 32 | Under 11 | $288 |
| Lidocaine Generic | 29 | 33 | Under 11 | $2,618 |
| Buprenorphine Generic | 25 | 25 | Under 11 | $9,241 |
Brand drugs: 357 claims; generic drugs: 791 claims; opioid claims: 361.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Watson $182 ($182 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $134.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.